NASDAQ: SLDBSolid Biosciences Inc Stock Ownership - Who owns Solid Biosciences?
Insider buying vs selling
Have Solid Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ilan Ganot | Director | 2026-01-28 | 191 | $6.59 | $1.26kSell |
| Kevin Tan | CFO Treasurer | 2026-01-13 | 5,704 | $5.27 | $30.06kSell |
| Ilan Ganot | Director | 2026-01-05 | 1,053 | $5.43 | $5.72kSell |
| Paul Herzich | Chief Technology Officer | 2025-12-03 | 2,701 | $5.11 | $13.80kSell |
| Alexander Cumbo | President and CEO | 2025-12-03 | 10,808 | $5.11 | $55.23kSell |
| David T. Howton | Chief Operating Officer | 2025-12-03 | 4,932 | $5.11 | $25.20kSell |
| Jessie Hanrahan | Chief Regulatory Officer | 2025-12-03 | 4,483 | $5.11 | $22.91kSell |
| Ilan Ganot | Director | 2025-11-10 | 3,278 | $4.12 | $13.51kSell |
| Gabriel Brooks | Chief Medical Officer | 2025-10-20 | 2,895 | $5.96 | $17.25kSell |
| Clare Kahn | Director | 2025-03-11 | 1,860 | $5.34 | $9.92kBuy |
SLDB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SLDB insiders and whales buy or sell their stock.
SLDB Shareholders
What type of owners hold Solid Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rajeev M. Shah | 17.05% | 13,281,046 | $87.65M | Insider |
| Perceptive Advisors LLC | 15.19% | 11,833,539 | $78.10M | Institution |
| Ra Capital Management LP | 15.00% | 11,689,948 | $77.15M | Insider |
| Bain Capital Life Sciences Investors LLC | 10.15% | 7,911,669 | $52.22M | Institution |
| Ultragenyx Pharmaceutical Inc | 10.04% | 7,825,797 | $51.65M | Insider |
| Siren LLC | 9.52% | 7,415,905 | $48.94M | Institution |
| Ra Capital Management LP | 7.46% | 5,811,423 | $38.36M | Institution |
| Gilad David Hayeem | 6.59% | 5,136,501 | $33.90M | Insider |
| Bain Capital Life Sciences Investors LLC | 6.46% | 5,034,582 | $33.23M | Insider |
| Blackrock Inc | 6.06% | 4,725,118 | $31.19M | Institution |
SLDB vs Biotech Stocks
Solid Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.